Alexandra MacLean
2023
In 2023, Alexandra MacLean earned a total compensation of $1.2M as Chief Executive Officer at AVENUE THERAPEUTICS, a 304% increase compared to previous year.
Compensation breakdown
| Option Awards | $800,000 |
|---|---|
| Salary | $400,000 |
| Other | $13,200 |
| Total | $1,213,200 |
MacLean received $800K in option awards, accounting for 66% of the total pay in 2023.
MacLean also received $400K in salary and $13.2K in other compensation.
Rankings
In 2023, Alexandra MacLean's compensation ranked 1,004th out of 2,978 executives tracked by ExecPay. In other words, MacLean earned more than 66.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,004 out of 2,978 | 66th |
Division Manufacturing | 598 out of 1,637 | 64th |
Major group Chemicals And Allied Products | 410 out of 906 | 55th |
Industry group Drugs | 399 out of 869 | 54th |
Industry Pharmaceutical Preparations | 272 out of 627 | 57th |
Source: SEC filing on May 3, 2024.
MacLean's colleagues
We found one more compensation record of an executive who worked with Alexandra MacLean at AVENUE THERAPEUTICS in 2023.
2023
David Jin
AVENUE THERAPEUTICS